NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

AI is becoming the foundation of the “largest infrastructure buildout in human history,” spanning energy and computing infrastructure, AI models and applications, NVIDIA founder and CEO Jensen Huang said during a World Economic Forum…

NVIDIA kicked off the year at CES, where the crowd buzzed about the latest gaming announcements — including the native GeForce NOW app for Linux and Amazon Fire TV sticks, community-requested flight-control support and a stacked AAA lineup…

Siemens and NVIDIA today announced a significant expansion of their strategic partnership to bring artificial intelligence into the real world.

NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry.

NVIDIA today announced a major expansion of NVIDIA BioNeMo™, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery.

NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry.

Startup works with leading cell therapy companies to bring robotics manufacturing into the clean room, reducing costs by more than 70% while accelerating output compared with legacy systems.